StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q3 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.42+0.02 (+0.31%)

Close on Nov 13, 2026Market cap $243.02MP/E –Yield –

Lifecore Biomedical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lifecore Biomedical's price to sales ratio was 1.9× on Nov 11, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 1.0× to 3.1×, with a median of 2.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×−0.5
2025Dec 31, 20252.4×+0.6
2024Dec 31, 20241.8×−0.0
2023Dec 29, 20231.8×+0.1
2022Dec 30, 20221.7×−1.0
2021Dec 31, 20212.8×+2.1
2020Dec 31, 20200.7×+0.1
2019Dec 31, 20190.6×−0.0
2018Dec 31, 20180.6×−0.1
2017Dec 29, 20170.7×−0.0
2016Dec 30, 20160.7×+0.1
2015Dec 31, 20150.6×−0.1
2014Dec 31, 20140.7×+0.0
2013Dec 31, 20130.7×+0.0
2012Dec 31, 20120.7×+0.2
2011Dec 30, 20110.5×+0.5
2010Dec 31, 20100.0×–

More Lifecore Biomedical figures

See a number that looks wrong?